| Auburn Osteopathic Medical Clinic | |
|
820 Harvey Rd Ste E Auburn WA 98002-4247 | |
| (253) 939-1066 | |
| (253) 939-1069 |
| Full Name | Auburn Osteopathic Medical Clinic |
|---|---|
| Speciality | Family Medicine |
| Location | 820 Harvey Rd, Auburn, Washington |
| Authorized Official Name and Position | Sheila Z Kennedy (PRESIDENT) |
| Authorized Official Contact | 2539391066 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Auburn Osteopathic Medical Clinic 820 Harvey Rd Ste E Auburn WA 98002-4247 Ph: (253) 939-1066 | Auburn Osteopathic Medical Clinic 820 Harvey Rd Ste E Auburn WA 98002-4247 Ph: (253) 939-1066 |
| NPI Number | 1831362938 |
|---|---|
| Provider Enumeration Date | 04/09/2008 |
| Last Update Date | 04/09/2013 |
| Medicare PECOS PAC ID | 3375616444 |
|---|---|
| Medicare Enrollment ID | O20080723000101 |
News Archive
An area of the brain called the orbitofrontal cortex is responsible for decisions made on the spur of the moment, but not those made based on prior experience or habit, according to a new basic science study from substance abuse researchers at the University of Maryland School of Medicine and the National Institute on Drug Abuse (NIDA). Scientists had previously believed that the area of the brain was responsible for both types of behavior and decision-making.
Adhering to an anti-inflammatory diet was associated with lower risks of dying from any cause, dying from cardiovascular causes, and dying from cancer in a recent Journal of Internal Medicine study.
Implantable fibers have been an enormous boon to brain research, allowing scientists to stimulate specific targets in the brain and monitor electrical responses.
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a new supply agreement with Laboratorios Grifols, S.A. for the development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags.
Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Center, Amsterdam, The Netherlands.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831362938 | NPI | - | NPPES |
| 193400000X | Other | WA | TAXONOMY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OP00001065 (Washington) | Primary |
| Provider Name | Sheila Z Kennedy |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1083618409 PECOS PAC ID: 3678645728 Enrollment ID: I20080707000167 |
News Archive
An area of the brain called the orbitofrontal cortex is responsible for decisions made on the spur of the moment, but not those made based on prior experience or habit, according to a new basic science study from substance abuse researchers at the University of Maryland School of Medicine and the National Institute on Drug Abuse (NIDA). Scientists had previously believed that the area of the brain was responsible for both types of behavior and decision-making.
Adhering to an anti-inflammatory diet was associated with lower risks of dying from any cause, dying from cardiovascular causes, and dying from cancer in a recent Journal of Internal Medicine study.
Implantable fibers have been an enormous boon to brain research, allowing scientists to stimulate specific targets in the brain and monitor electrical responses.
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a new supply agreement with Laboratorios Grifols, S.A. for the development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags.
Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Center, Amsterdam, The Netherlands.
› Verified 9 days ago
News Archive
An area of the brain called the orbitofrontal cortex is responsible for decisions made on the spur of the moment, but not those made based on prior experience or habit, according to a new basic science study from substance abuse researchers at the University of Maryland School of Medicine and the National Institute on Drug Abuse (NIDA). Scientists had previously believed that the area of the brain was responsible for both types of behavior and decision-making.
Adhering to an anti-inflammatory diet was associated with lower risks of dying from any cause, dying from cardiovascular causes, and dying from cancer in a recent Journal of Internal Medicine study.
Implantable fibers have been an enormous boon to brain research, allowing scientists to stimulate specific targets in the brain and monitor electrical responses.
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a new supply agreement with Laboratorios Grifols, S.A. for the development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags.
Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Center, Amsterdam, The Netherlands.
› Verified 9 days ago
Holistic Family Care Clinic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 721 M St Ne Ste 105, Auburn, WA 98002 Phone: 253-766-1161 Fax: 253-804-5655 | |
Sea Mar Chc Auburn Behavioral Health-division St Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 202 N Division St Ste 300, Auburn, WA 98001 Phone: 206-763-5277 | |
Sea Mar Chc Auburn Mountainview High School Medical Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 28900 124th Ave Se, Auburn, WA 98092 Phone: 532-942-1202 Fax: 253-294-2122 | |
Healthpoint Auburn North Annex Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 915 Auburn Way N Ste B, Auburn, WA 98002 Phone: 425-277-1311 | |
Emmal Felipe Enterprises Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1340 M St Se, Suite A, Auburn, WA 98002 Phone: 253-735-2777 Fax: 253-735-4153 | |
Internal Medicine Consultants Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3130 S 381st Way, Auburn, WA 98001 Phone: 206-963-9052 Fax: 206-274-8164 | |
Internal Medicine Clinic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 202 Auburn Ave, Auburn, WA 98002 Phone: 253-833-1735 Fax: 253-833-8515 |